Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
16.38
+1.14 (7.48%)
Apr 29, 2026, 4:08 PM HKT
Market Cap 6.96B
Revenue (ttm) 146.34M
Net Income (ttm) -379.87M
Shares Out 456.82M
EPS (ttm) -0.88
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,094,400
Average Volume 897,735
Open 15.24
Previous Close 15.24
Day's Range 14.97 - 16.98
52-Week Range 14.95 - 74.00
Beta n/a
RSI 32.90
Earnings Date May 6, 2026

About HKG:2591

Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in the development of drugs. The company’s products are used for the treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 193
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2591
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.